What Is Thymosin Alpha-1? The Thymic Peptide, Explained

The gist

The thymosin alpha 1 peptide is a small protein the body makes on its own. It is a chain of 28 amino acids (protein building blocks) with a small chemical cap on one end, made in the thymus — a gland that trains immune cells. Its drug name is thymalfasin, and the synthetic version is an exact copy of the natural one. Its job is to help the immune system respond: it nudges scout cells and T cells into action while keeping the response from overreacting. People confuse it constantly with similarly named peptides — especially TB-500 — but it is a genuinely different molecule with a different size, sequence, and purpose. This page lays out what it is, then sorts it apart from its look-alikes so the names stop blurring together.

Thymalfasin: structure and identity

Thymalfasin is the International Nonproprietary Name for synthetic Thymosin Alpha-1 — the sequence-identical version studied in trials. The molecule is a 28-amino-acid, N-terminally acetylated polypeptide with a molecular weight of about 3,108 daltons and the CAS number 62304-98-7. It is highly acidic, has no aromatic residues and no disulfide bonds, and in the body is cleaved from a larger 113-amino-acid precursor called prothymosin alpha. The acetyl cap on its N-terminus is not decoration — it is required for biological activity. It was first isolated from calf thymus and sequenced by Goldstein's group in 1977 ^[1], and its circulating level declines with age, which is part of why it draws interest as an immune-restorative.

Ta1 peptide: what it does in the body

As the Ta1 peptide (a common shorthand for Thymosin Alpha-1), its function is immune modulation, not growth or repair of tissue. It signals through Toll-like receptors TLR2 and TLR9 on dendritic cells and monocytes, driving them to mature and present antigen, which matures T cells and promotes a Th1 (cell-mediated defense) response. At the same time it activates the enzyme IDO, generating IL-10 and regulatory T cells — a built-in brake ^[5]. That two-sided action is the whole point: it can restore effector immunity in a worn-down or immunosuppressed state while damping a hyperinflammatory one. It also activates natural killer cells and restores monocyte HLA-DR expression, a marker of recovered immune function.

Thymosin alpha 1 vs thymosin beta 4 — and three other look-alikes

The single most important thing to get right is that Thymosin Alpha-1 is not the same molecule as several similarly named peptides. In the thymosin alpha 1 vs thymosin beta 4 question specifically: thymosin beta-4 (TB-500) is a 43-amino-acid actin-binding peptide studied for tissue repair — a different sequence, a different size, a different mechanism, and a different use; it is also the one that is WADA-prohibited. Thymosin Alpha-1, by contrast, is a 28-amino-acid immunomodulator and is not a tissue-repair or actin-binding peptide.

The other look-alikes: thymulin (FTS) is a zinc-dependent nonapeptide (nine amino acids) — far smaller, and zinc-bound. Thymopentin (TP-5) is a pentapeptide (five amino acids), a fragment-based immunomodulator. Thymalin is a separate bovine thymic-extract preparation, not a single defined peptide. And prothymosin alpha is the larger 113-amino-acid precursor from which Thymosin Alpha-1 is cleaved — related, but a different molecule. Different sequence, different size, different mechanism, different use, in every case. When a source treats these as interchangeable, it is wrong.